Last reviewed · How we verify

NCT04000880: AMPLIFY

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

Active, enrolled NA Last updated 12 June 2025
What this trial tests

NA trial testing Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health in Breast Cancer in 603 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
4 March 2020
Primary endpoint
1 April 2025
1 September 2025

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment603
Start date4 March 2020
Primary completion1 April 2025
Estimated completion1 September 2025
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

50 and older, any sex, with Breast Cancer or Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study will test the efficacy of interactive, web-based interventions that improve diet, physical activity and weight management changes among early stage survivors of breast, prostate, colorectal, endometrial, renal, thyroid, and ovarian cancers, as well as multiple myeloma and non-Hodgkin Lymphoma. Overarching outcomes also include physical function and performance, muscle mass, quality of life, and health utilities.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer.
    Yasin HK, Taylor AH, Ayakannu T. · · 2021 · cited 41× · PMID 33946913 · DOI 10.3390/cancers13092149
  2. Dietary interventions for adult cancer survivors.
    Burden S, Jones DJ, Sremanakova J, Sowerbutts AM, et al · · 2019 · cited 41× · PMID 31755089 · DOI 10.1002/14651858.cd011287.pub2
  3. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
    Agnew H, Kitson S, Crosbie EJ. · · 2023 · cited 16× · PMID 36971688 · DOI 10.1002/14651858.cd012513.pub3
  4. Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) cancer survivor health: program project protocols for remote lifestyle intervention and assessment in 3 inter-related randomized controlled trials among survivors of obesity-related cancers.
    Pekmezi D, Fontaine K, Rogers LQ, Pisu M, et al · · 2022 · cited 12× · PMID 35488238 · DOI 10.1186/s12885-022-09519-y
  5. Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancer.
    Garcia MB, Schadler KL, Chandra J, Clinton SK, et al · · 2023 · cited 11× · PMID 36825928 · DOI 10.3322/caac.21773
  6. How Healthy Are the Diets of Cancer Survivors? Characteristics of Those Most at Risk and Opportunities for Improvement.
    Kaur H, Pisu M, Pekmezi DW, Rogers LQ, et al · · 2025 · cited 3× · PMID 40359987 · DOI 10.6004/jnccn.2025.7012
  7. Behind the Numbers: Cancer Survivor Recruitment by Demographics and Clinical Status.
    Martin MY, Demark-Wahnefried W, Omairi I, Schoenberger-Godwin YM, et al · · 2026 · PMID 41998846 · DOI 10.1002/cam4.71782
  8. Supporting Cancer Survivors in Making Healthful Lifestyle Changes.
    Demark-Wahnefried W, Bail JR, Hoenemeyer T, Pekmezi DW, et al · · 2020 · PMID 41567983 · DOI 10.1080/10463356.2020.1720373

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04000880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing